Clinical trials sponsored by National Heart, Lung, and Blood Institute (NHLBI)

Phase breakdown

Conditions studied

Recruiting trials led by National Heart, Lung, and Blood Institute (NHLBI)

• Causes and Natural History of Dyslipidemias
  NCT00353782 · Phase: Not specified · Ages: 2 Years to 100 Years · Sex: All (male and female) · 1 location
• Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
  NCT01143454 · Phase: Not specified · Ages: 1 Year to 100 Years · Sex: All (male and female) · 3 locations
• Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
  NCT06313398 · Phase: Early Phase 1 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
  NCT06032923 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 120 Years · Sex: Female · 1 location
• Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
  NCT07566494 · Phase: Phase 1 · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
  NCT07613099 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
  NCT03685721 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
  NCT01927783 · Phase: Not specified · Ages: 19 Years to 85 Years · Sex: All (male and female) · 1 location
• Natural History of Sickle Cell Disease
  NCT00081523 · Phase: Not specified · Ages: 2 Years to 90 Years · Sex: All (male and female) · 3 locations
• Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
  NCT05724121 · Phase: Not specified · Ages: 18 Years to 110 Years · Sex: All (male and female) · 1 location
• Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
  NCT05213572 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
  NCT07599176 · Phase: Phase 1, Phase 2 · Ages: 4 Years to 65 Years · Sex: All (male and female) · 1 location
• Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels
  NCT04008368 · Phase: Phase 1, Phase 2 · Ages: 2 Years to 80 Years · Sex: All (male and female) · 1 location
• Role of Genetic Factors in the Development of Lung Disease
  NCT00001532 · Phase: Not specified · Ages: 2 Years to 90 Years · Sex: All (male and female) · 4 locations
• Study of Intravenous ZMA001 in Healthy Subjects
  NCT05967299 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Study of Skin Tumors in Tuberous Sclerosis
  NCT00001975 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Study of the Disease Process of Lymphangioleiomyomatosis
  NCT00001465 · Phase: Not specified · Ages: 16 Years to 100 Years · Sex: All (male and female) · 1 location
• Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
  NCT05904093 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
  NCT03288207 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 75 Years · Sex: Female · 1 location
• Technical Development of Cardiovascular Magnetic Resonance Imaging
  NCT04927429 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 2 locations
• Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
  NCT03581318 · Phase: Not specified · Ages: 7 Years to 100 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is National Heart, Lung, and Blood Institute (NHLBI) recruiting for?

National Heart, Lung, and Blood Institute (NHLBI) is the lead sponsor of 21 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.